Journal List > Korean J Nutr > v.43(4) > 1043833

Park, Kim, Lee, and Lee: The Effect of Green Coffee Bean Extract Supplementation on Body Fat Reduction in Overweight/Obese Women

Abstract

This study was performed to examine the diet effect of green coffee bean extract on body fat reduction. Overweight/obese women (body mass index > 23 kg/m2 or body fat > 27%) who were not diagnosed any type of disease were included in this study and subjects were randomly assigned to green coffee bean extract group (n = 23) or placebo group (n = 20). We measured anthropometric parameters, abdominal fat distribution by computed tomography and blood components before and after the 8-weeks intervention period. After supplementation, green coffee bean extract group showed a significant reduction of body weight (p < 0.01), body fat percent (p < 0.01), total fat area at L1 vertebra (-4.8%, p < 0.05) and visceral fat area at L4 vertebra was(-4.7%, p < 0.05). In addition, total fat area and visceral fat area at L1 vertebra decreased significantly in green coffee bean extract group compared with placebo group (p < 0.05, p < 0.05 respectively). The result of present study demonstrated that the supplementation of green coffee bean extract for 8 weeks can give beneficial effects on body fat reduction and visceral fat accumulation.

Figures and Tables

Fig. 1
Changed values in total fat, visceral fat and subcutaneous fat at L1 and L4 between control group and test group. mean ± S.E. P-value compared with changed values of placebo group.
kjn-43-374-g001
Table 1
Anthropometric parameters and blood pressure in overweight women before and after intervention
kjn-43-374-i001

mean ± S.E. 1) Blood pressure. No significant differences in initial value between placebo and test group. pa: compared with initial value in placebo group by Wilcoxon singed ranked test. pb: compared with initial value in test group by Wilcoxon singed ranked test. pc: compared with changed value between placebo and test group by Mann-Whitney test.

Table 2
Dietary food intake and total energy expenditure in overweight women before and after intervention
kjn-43-374-i002

mean ± S.E. 1) Visceral/subcutaneous fat ratio. No significant differences in initial value between placebo and test group. pa: compared with initial value in placebo group by Wilcoxon singed ranked test. pb: compared with initial value in test group by Wilcoxon singed ranked test. pc: compared with changed value between placebo and test group by Mann-Whitney test.

Table 3
Fat and muscle areas at different levels of body in overweight women before and after intervention
kjn-43-374-i003

mean ± S.E. 1) Visceral/subcutaneous fat ratio. No significant differences in initial value between placebo and test group. pa: compared with initial value in placebo group by Wilcoxon singed ranked test. pb: compared with initial value in test group by Wilcoxon singed ranked test.

Table 4
Lipid profiles, apolipoproteins and fasting glucose levels in overweight women before and after intervention
kjn-43-374-i004

mean ± S.E. 1) Atherogenic index = (Total cholesterol-HDL cholesterol)/HDL cholesterol. No significant differences in initial value between placebo and test group. pa: compared with initial value in placebo group by Wilcoxon singed ranked test. pb: compared with initial value in test group by Wilcoxon singed ranked test. pc: compared with changed value between placebo and test group by Mann-Whitney test.

Notes

This study was supported by a grants of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0015017, M10642120-002-06N4212-00210).

References

1. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. 2000. Geneva:
2. Ministry of Health and Welfare the Third Korea National Health & Nutrition Examination Survey (KNHANES III) 2007 Nutrition Survey. 2007.
3. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004. 89(6):2583–2589.
crossref
4. Kim KJ, Park SK. Changes in major chemical constituents of green coffee beans during the roasting. Korean J Food Sci Technol. 2006. 38(2):153–158.
5. Ranheim T, Halvorsen B. Coffee consumption and human health-beneficial or detrimental?-Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res. 2005. 49(3):274–284.
crossref
6. Greenberg JA, Boozer CN, Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr. 2006. 84(4):682–693.
crossref
7. Van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002. 360(9344):1477–1478.
crossref
8. Farah A, Monteiro M, Donangelo CM, Lafay S. Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr. 2008. 138(12):2309–2315.
crossref
9. Suzuki A, Kagawa D, Ochiai R, Tokimitsu I, Saito I. Green coffee bean extract and its metabolites have a hypotensive effect in spontaneously hypertensive rats. Hypertens Res. 2002. 25(1):99–107.
crossref
10. Watanabe T, Arai Y, Mitsui Y, Kusaura T, Okawa W, Kajihara Y, Saito I. The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin Exp Hypertens. 2006. 28(5):439–449.
crossref
11. Ochiai R, Jokura H, Suzuki A, Tokimitsu I, Ohishi M, Komai N, Rakugi H, Ogihara T. Green coffee bean extract improves human vasoreactivity. Hypertens Res. 2004. 27(10):731–737.
crossref
12. Shimoda H, Seki E, Aitani M. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med. 2006. 6:1–9.
crossref
13. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr. 1956. 4(1):20–34.
14. Rexrode KM, Buring JE, Manson JE. Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord. 2001. 25(7):1047–1056.
crossref
15. Folsom AR, Prineas RJ, Kaye SA, Munger RG. Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke. 1990. 21:701–706.
crossref
16. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990. 10:497–511.
crossref
17. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol. 1997. 145:614–619.
crossref
18. Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, Willett WC. Body size and fat distribution as predictors of coronary heart disease among middleaged and older US men. Am J Epidemiol. 1995. 141:1117–1127.
crossref
19. Kim JY, Han YS. Influence of roasting time on antibacterial and antioxidative effects of coffee extract. Korean J Food Cookery Sci. 2009. 25(4):496–505.
20. del Castillo MD, Ames JM, Gordon MH. Effect of roasting on the antioxidant activity of coffee brews. J Agric Food Chem. 2002. 50(13):3698–3703.
crossref
21. Gordon MH, Wishart K. Effects of Chlorogenic Acid and Bovine Serum Albumin on the Oxidative Stability of Low Density Lipoproteins in Vitro. J Agric Food Chem. 2010. 13:[Epub ahead of print].
crossref
22. McCarty MF. A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk. Med Hypotheses. 2005. 64(4):848–853.
crossref
23. Cho AS, Jeon SM, Kim MJ, Yeo J, Seo KI, Choi MS, Lee MK. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol. 2010. 48(3):937–943.
crossref
24. Li SY, Chang CQ, Ma FY, Yu CL. Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferator-activated receptor-alpha in golden hamsters fed on high fat diet. Biomed Environ Sci. 2009. 22(2):122–129.
crossref
25. Zheng G, Sayama K, Okubo T, Juneja LR, Oguni I. Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo. 2004. 18(1):55–62.
26. Arciero PJ, Bougopoulos CL, Nindl BC, Benowitz NL. Influence of age on the thermic response to caffeine in women. Metabolism. 2000. 49(1):101–107.
crossref
27. Acheson KJ, Gremaud G, Meirim I, Montigon F, Krebs Y, Fay LB, Gay LJ, Schneiter P, Schindler C, Tappy L. Metabolic effects of caffeine in humans: lipid oxidation or futile cycling? Am J Clin Nutr. 2004. 79(1):40–46.
crossref
28. Suh HJ. Effect of prolonged garcinia extracts ingestion on exercise performance and body deposition. Korean J Exerc Nutr. 2004. 8(1):43–48.
29. Okasora K, Takaya R, Tokuda M, Fukunaga Y, Oguni T, Tanaka H, Konishi K, Tamai H. Comparison of bioelectrical impedance analysis and dual energy X-ray absorptiometry for assessment of body composition in children. Pediatr Int. 1999. 41(2):121–125.
crossref
TOOLS
Similar articles